These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, Truong C, Schmitt E, Sifry-Platt M, Lucioli S, Santorelli FM, Ficicioglu CH, Rodriguez M, Wierenga K, Enns GM, Longo N, Lipson MH, Vallance H, Craigen WJ, Scaglia F, Wong LJ. Hum Mutat; 2008 Feb; 29(2):330-1. PubMed ID: 18205204 [Abstract] [Full Text] [Related]
5. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N. Nat Genet; 2001 Nov; 29(3):337-41. PubMed ID: 11687800 [Abstract] [Full Text] [Related]
9. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Mousson de Camaret B, Taanman JW, Padet S, Chassagne M, Mayençon M, Clerc-Renaud P, Mandon G, Zabot MT, Lachaux A, Bozon D. Biochem J; 2007 Mar 01; 402(2):377-85. PubMed ID: 17073823 [Abstract] [Full Text] [Related]
13. Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature. Grabhorn E, Tsiakas K, Herden U, Fischer L, Freisinger P, Marquardt T, Ganschow R, Briem-Richter A, Santer R. Liver Transpl; 2014 Apr 01; 20(4):464-72. PubMed ID: 24478274 [Abstract] [Full Text] [Related]